Supreme Court Report

Supreme Court of the United States · Official docket →

Novartis Pharmaceuticals Corporation, Applicant v. HEC Pharm Co., Ltd., et al.

Application · United States Court of Appeals for the Federal Circuit, No. 2021-1070

Application denied · October 13, 2022

Counsel of record

For petitioner
William McGinley Jay
Goodwin Procter, LLP

For respondent
Peter K. Stris
Stris and Maher LLP

Case

Conference history
—

Proceedings

  1. Oct 13 2022
    Application (22A272) referred to the Court.
  2. Oct 13 2022
    Application (22A272) for stay of the mandate presented to The Chief Justice and by him referred to the Court is denied. The order heretofore entered by The Chief Justice is vacated.
  3. Oct 11 2022
    Supplemental letter from applicant filed.
    Main DocumentOther
  4. Oct 11 2022
    Supplemental letter from respondents filed.
    Main Document
  5. Oct 07 2022
    Reply of applicant Novartis Pharmaceuticals Corporation filed.
    ReplyProof of Service
  6. Oct 05 2022
    Response to application from respondent HEC Pharm Co., Ltd., et al. filed.
    Main DocumentMain DocumentProof of Service
  7. Sep 29 2022
    Upon consideration of the application of counsel for the applicant, it is ordered that the mandate of the United States Court of Appeals for the Federal Circuit, case No. 2021-1070, is hereby stayed pending further order of The Chief Justice or of the Court. It is further ordered that a response to the application be filed on or before Wednesday, October 5, 2022, by noon (EDT).
  8. Sep 28 2022
    Application (22A272) for a stay, submitted to The Chief Justice.
    Main DocumentLower Court Orders/OpinionsProof of Service